ATRACURIUM Side Effects

5527881-2 | Ventricular Fibrillation
on Nov 08, 2007 Female patient from UNITED KINGDOM , 85 years of age, was diagnosed with perioperative analgesia, prophylaxis of nausea and vomiting and was treated with Atracurium (View Usage). Patient experienced the following unwanted or unexpected effects: ventricular fibrillation. Atracurium dosage: 40 Mg Once Iv. During the same period patient was treated with GRANISETRON (0.2 Mg Freq Iv) (View Granisetron Review and Granisetron Label ), ALENDRONIC ACID (View Alendronic Acid Review and Alendronic Acid Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), BETAXOLOL (View Betaxolol Review and Betaxolol Label ), BUMETANIDE (View Bumetanide Review and Bumetanide Label ), CALCIUM CARBONATE (View Calcium Carbonate Review and Calcium Carbonate Label ), CEFUROXIME (View Cefuroxime Review and Cefuroxime Label ), CO CODAMOL (View Co-codamol Review and Co-codamol Label ).

5055354-2 | Anaesthetic Complication, Anaphylactoid Shock
Patient was taking Atracurium (View Usage). Patient had the following side effects: anaesthetic complication, anaphylactoid shock on Jun 29, 2006 from FRANCE Additional patient health information: Female patient , weighting 141.1 lb, . Atracurium dosage: 0.5 Mg/kg Once Iv. During the same period patient was treated with MIDAZOLAM HYDROCHLORIDE (View Midazolam Hydrochloride Review and Midazolam Hydrochloride Label ), FENTANYL (View Fentanyl Review and Fentanyl Label ), DIPRIVAN (View Diprivan Review and Diprivan Label ), TRACRIUM (View Tracrium Review and Tracrium Label ).

5034717-5 | Accidental Exposure, Bradycardia Neonatal, Bronchiolitis, Bronchopneumonia, Cyanosis Neonatal, Developmental Delay, Electroencephalogram Abnormal, Hyperglycaemia
Adverse event was reported on Jun 08, 2006 by a Male patient taking Atracurium (View Usage) (Dosage: 10 Mg Once Im) . Location: TAIWAN, PROVINCE OF CHINA , weighting 8.32 lb, After Atracurium was administered, patient had the following side effects: accidental exposure, bradycardia neonatal, bronchiolitis, bronchopneumonia, cyanosis neonatal, developmental delay, electroencephalogram abnormal, hyperglycaemia. Patient was hospitalized.

5034716-3 | Blood Creatine Phosphokinase Increased, Bradycardia Neonatal, Cyanosis Neonatal, Developmental Delay, Hyperglycaemia, Infantile Apnoeic Attack, Neonatal Disorder, Neonatal Respiratory Failure
on Jun 08, 2006 Female patient from TAIWAN, PROVINCE OF CHINA , weighting 8.58 lb, was treated with Atracurium (View Usage). Patient experienced the following unwanted or unexpected effects: blood creatine phosphokinase increased, bradycardia neonatal, cyanosis neonatal, developmental delay, hyperglycaemia, infantile apnoeic attack, neonatal disorder, neonatal respiratory failure. Atracurium dosage: 10 Mg Once Im. Patient was hospitalized.


5034715-1 | Accidental Exposure, Blood Creatine Phosphokinase Increased, Bradycardia Neonatal, Cyanosis Neonatal, Hyperglycaemia, Infantile Apnoeic Attack, Neonatal Respiratory Alkalosis
on Jun 08, 2006 Female patient from TAIWAN, PROVINCE OF CHINA , weighting 6.78 lb, was treated with Atracurium (View Usage). Patient had the following side effects: accidental exposure, blood creatine phosphokinase increased, bradycardia neonatal, cyanosis neonatal, hyperglycaemia, infantile apnoeic attack, neonatal respiratory alkalosis. Atracurium dosage: 10 Mg Once Im. Patient was hospitalized.

4974673-9 | Completed Suicide, Intentional Overdose
Patient was taking Atracurium (View Usage). After Atracurium was administered, patient had the following side effects: completed suicide, intentional overdose on Mar 29, 2006 from SPAIN Additional patient health information: Male patient , 45 years of age, was diagnosed with completed suicide and. Atracurium dosage: . During the same period patient was treated with VENLAFAXINE HCL (View Venlafaxine Hcl Review and Venlafaxine Hcl Label ).

4640740-2 | Anaesthetic Complication, Cyanosis, Electrocardiogram St Segment Depression, Hypotension, Hypoxia
Adverse event was reported on Dec 16, 2004 by a Female patient taking Atracurium (View Usage) (Dosage: 25 Microgram Freq Iv) was diagnosed with induction of anaesthesia and. Location: , 29 years of age, Patient experienced the following unwanted or unexpected effects: anaesthetic complication, cyanosis, electrocardiogram st segment depression, hypotension, hypoxia. During the same period patient was treated with PROPOFOL (200 Mg Freq Unk Iv) (View Propofol Review and Propofol Label ), METOCLOPRAMIDE (10 Mg Freq Iv) (View Metoclopramide Review and Metoclopramide Label ), ALFENTANIL (60 Microgram Freq Unk Iv) (View Alfentanil Review and Alfentanil Label ).

4616985-4 | Angioneurotic Oedema, Hypotension, Skin Test Positive, Tachycardia
on Mar 04, 2005 Female patient from , 44 years of age, was diagnosed with anaesthesia and was treated with Atracurium (View Usage). Patient had the following side effects: angioneurotic oedema, hypotension, skin test positive, tachycardia. Atracurium dosage: Iv. During the same period patient was treated with SUXAMETHONIUM (100 Mg Iv) (View Suxamethonium Review and Suxamethonium Label ), EVENING PRIMROSE OIL (View Evening Primrose Oil Review and Evening Primrose Oil Label ), COD LIVER OIL (View Cod Liver Oil Review and Cod Liver Oil Label ), PYRIDOXINE HCL (View Pyridoxine Hcl Review and Pyridoxine Hcl Label ), CALCIUM GLUCONATE (View Calcium Gluconate Review and Calcium Gluconate Label ), ZINC (View Zinc Review and Zinc Label ).

4596495-3 | Bronchospasm, Hypoventilation, Oxygen Saturation Decreased
on Feb 11, 2005 Female patient from , 25 years of age, was diagnosed with life support and was treated with Atracurium (View Usage). After Atracurium was administered, patient had the following side effects: bronchospasm, hypoventilation, oxygen saturation decreased. Atracurium dosage: 20 Mg Freq Iv.